Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$415,795
New position
Shares Held
7,932
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#518
of 1,032 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lionhunter Capital Management, LLC holds $24,392,906 across 8 Drug Manufacturers - General names. GSK ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,371 | $14,838,149 | |
| 2 | JNJ |
Johnson & Johnson
|
12,698 | $3,224,911 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,789 | $1,900,386 | |
| 4 | PFE |
Pfizer Inc
|
56,887 | $1,369,838 | |
| 5 | ABBV |
AbbVie Inc.
|
4,730 | $1,190,257 | |
| 6 | AZN |
Astrazeneca PLC
|
6,000 | $1,137,720 | |
| 7 | GSK |
GSK plc
This page
|
7,932 | $415,795 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,500 | $315,850 |
All Filings in GSK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415,795 | 7,932 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||